Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Leukemia|May 22, 2021
The balance between the intronic miR-342 and its host gene Evl determines hematopoietic cell fate decisionFriederike Herbst, Tonio J L Lang, Elias S P Eckert, et al.British Journal of Haematology|September 17, 2013
Targeted resequencing for analysis of clonal composition of recurrent gene mutations in chronic lymphocytic leukaemiaAlexander Jethwa, Jennifer Hüllein, Tatjana Stolz, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|March 3, 2011
Lentiviral vector integration profiles differ in rodent postmitotic tissuesCynthia C Bartholomae, Anne Arens, Kamaljit S Balaggan, et al.Current Gene Therapy|May 19, 2015
Successful Combination of Sequential Gene Therapy and Rescue Allo-HSCT in Two Children with X-CGD - Importance of TimingUlrich Siler, Anna Paruzynski, Heidi Holtgreve-Grez, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|January 10, 2013
The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesisAli Nowrouzi, Wing T Cheung, Tingting Li, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|August 25, 2011
Insertion sites in engrafted cells cluster within a limited repertoire of genomic areas after gammaretroviral vector gene therapyAnnette Deichmann, Martijn H Brugman, Cynthia C Bartholomae, et al.Science Translational Medicine|March 14, 2014
Gene therapy for Wiskott-Aldrich syndrome--long-term efficacy and genotoxicityChristian Jörg Braun, Kaan Boztug, Anna Paruzynski, et al.Nature Medicine|December 8, 2009
Comprehensive genomic access to vector integration in clinical gene therapyRichard Gabriel, Ralph Eckenberg, Anna Paruzynski, et al.Nature|July 6, 2017
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancerUgur Sahin, Evelyna Derhovanessian, Matthias Miller, et al.Nature Medicine|January 6, 2025
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trialJuanita Lopez, Thomas Powles, Fadi Braiteh, et al.Pageof 2